Profiel
Pia Lindström worked as a Director of Regulatory Affairs at Neurocrine Biosciences, Maxim Pharmaceuticals, Kémia, and Quintiles.
She also worked as the VP of Regulatory Affairs and Quality Assurance at Intercept Pharmaceuticals from 2008 to 2012.
Lindström holds a graduate and doctorate degree from The University of North Carolina at Charlotte.
Eerdere bekende functies van Pia Lindström
| Bedrijven | Functie | Einde |
|---|---|---|
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Algemeen Adviseur | - |
Maxim Pharmaceuticals, Inc.
Maxim Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs, therapies and vaccines for cancer and infectious diseases | Algemeen Adviseur | - |
| NEUROCRINE BIOSCIENCES, INC. | Algemeen Adviseur | - |
Kémia, Inc.
Kémia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small molecule therapeutics | Algemeen Adviseur | - |
| INTERCEPT PHARMACEUTICALS, INC. | Algemeen Adviseur | - |
Opleiding van Pia Lindström
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Maxim Pharmaceuticals, Inc.
Maxim Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs, therapies and vaccines for cancer and infectious diseases | Health Technology |
Kémia, Inc.
Kémia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small molecule therapeutics | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















